Oneview HealthcareASX:ONE -9.68%42 PB Ratio is 17.50 as of Jun. 27, 2026, which is 168% above its 10-year median of 6.53. GuruFocus rates ASX:ONE with a GF Score™ of 42/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Oneview Healthcare ranks worse than 97.05% on this metric.
The historical rank and industry rank for Oneview Healthcare's PB Ratio or its related term are showing as below:
ASX:ONE'
s PB Ratio Range Over the Past 10 Years
Min: 0.48 Med: 6.53 Max: 49.38
Current: 17.5
During the past 10 years, Oneview Healthcare's highest PB Ratio was 49.38. The lowest was 0.48. And the median was 6.53.
ASX:ONE's PB Ratio is ranked worse than 97.05% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs ASX:ONE: 17.50
During the past 12 months, Oneview Healthcare's average Book Value Per Share Growth Rate was -72.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.50% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Oneview Healthcare was 9.00% per year. The lowest was -71.00% per year. And the median was -49.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Oneview Healthcare PB Ratio Related Terms
Oneview Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Oneview Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Oneview Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneview Healthcare PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oneview Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Oneview Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Oneview Healthcare (ASX:ONE) has a PB Ratio of 17.50 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Oneview Healthcare and its competitors. This is 168% above median its historical median of 6.53. Over the past decade, Oneview Healthcare's PB Ratio has ranged from 0.48 to 49.38. According to the industry distribution chart, Oneview Healthcare ranks #593 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 97.1%.
Is Oneview Healthcare's PB Ratio too high?
Oneview Healthcare's current PB Ratio of 17.50 is 168% above median its 10-year median of 6.53. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 49.38. The Healthcare Providers & Services industry median PB Ratio is 1.98. Oneview Healthcare's value of 17.50 is 783.8% above this industry median. Based on the distribution chart, Oneview Healthcare ranks #593 out of 611 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oneview Healthcare has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneview Healthcare's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Oneview Healthcare ranks #593 out of 611 companies for PB Ratio. This places Oneview Healthcare in the lower half of its industry. The industry median PB Ratio is 1.98. Oneview Healthcare's value of 17.50 is 783.8% above this benchmark. Historically, Oneview Healthcare's own PB Ratio has ranged from 0.48 to 49.38 over the past decade. While the company's 10-year median is 6.53 vs. the industry median of 1.98, Oneview Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oneview Healthcare's current PB Ratio of 17.50 is 783.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Oneview Healthcare and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneview Healthcare's current PB Ratio is 17.50, which is 168% above median its own 10-year median of 6.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneview Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oneview Healthcare (ASX:ONE) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.14 — trading 57.6% below its estimated fair value. The current PB Ratio is 17.50, which is 168% above median its 10-year median of 6.53 and 783.8% above the Healthcare Providers & Services industry median of 1.98. Oneview Healthcare's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Oneview Healthcare (ASX:ONE), the current PB Ratio is 17.50 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneview Healthcare (ASX:ONE) Overvalued in 2026?
Based on GuruFocus' analysis, Oneview Healthcare stock appears to be undervalued.
The current stock price of A$0.14 is trading 57.6% below its estimated GF Value™ of A$0.33.
GuruFocus considers Oneview Healthcare to be Possible Value Trap.
Key valuation signals for ASX:ONE:
PB Ratio: 17.50 (168% above median its 10-year median of 6.53)
GF Value™: A$0.33 vs. price of A$0.14 (57.6% below fair value)
Industry Position: 783.8% above the Healthcare Providers & Services median (#593 of 611)
No single metric tells the full story. See the ASX:ONE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. The company operates in one reportable segment, which provides a patient engagement solution for the healthcare sector.
42GF Score
Get the complete analysis for ASX:ONE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ONE has been successfully added to your 
